Amnestic disorder

Summary

Amnestic disorder (MONDO:0001152) is a disease and 3 clinical trials. A subtype of cognitive disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	amnestic disorder
Mondo ID	MONDO:0001152
DOID	DOID:10914
ICD-11	386330688
SNOMED CT	3298001
UMLS	C0002625
MedGen	1882
Is cancer (heuristic)	no

Disease family

This is a subtype of cognitive disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disorder › cognitive disorder › amnestic disorder

Related subtypes (5): dementia, alexia, psychotic disorder, delirium, subjective cognitive decline

Subtypes (4): transient global amnesia, retrograde amnesia, anterograde amnesia, alcohol amnestic disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02740634	Not specified	ACTIVE_NOT_RECRUITING	Molecular and Structural Imaging in Alzheimer’s Disease: A Longitudinal Study
NCT02265757	Not specified	COMPLETED	Behavioral Interventions to Prevent or Delay Dementia
NCT03095170	Not specified	TERMINATED	Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder